https://orcid.org/0000-0003-0210-4412
Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wenjuan Yang. (2023) Co-delivery of trifluralin and miltefosin with enhanced skin penetration and localization in Leishmania affected macrophages. Journal of Dispersion Science and Technology 0:0, pages 1-13.
Read now
Read now
Sibgha Batool, Fatima Zahid, Fakhar- Ud-Din, Syeda Sohaila Naz, Muhammad Junaid Dar, Muhammad Waseem Khan, Alam Zeb & Gul Majid Khan. (2021) Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis: in vitro and in vivo analyses. Drug Development and Industrial Pharmacy 47:3, pages 440-453.
Read now
Read now
Sara Salatin & Mitra Jelvehgari. (2020) Desirability function approach for development of a thermosensitive and bioadhesive nanotransfersome–hydrogel hybrid system for enhanced skin bioavailability and antibacterial activity of cephalexin. Drug Development and Industrial Pharmacy 46:8, pages 1318-1333.
Read now
Read now
Articles from other publishers (29)
Omnia Hesham Abdelhafez, Islam M. Abdel-Rahman, Eman Alaaeldin, Hesham Refaat, Refat El-Sayed, Sami A. Al-Harbi, Ahmed M. Shawky, Mohamed-Elamir F. Hegazy, Alaa Y. Moustafa & Nourhan Hisham Shady. (2023) Pro-Apoptotic Activity of Epi-Obtusane against Cervical Cancer: Nano Formulation, In Silico Molecular Docking, and Pharmacological Network Analysis. Pharmaceuticals 16:11, pages 1578.
Crossref
Crossref
Sidra Bashir, Kanwal Shabbir, Fakhar ud Din, Saif Ullah Khan, Zakir Ali, Barkat Ali Khan, Dong Wuk Kim & Gul Majid Khan. (2023) Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect. Heliyon 9:11, pages e21939.
Crossref
Crossref
Jiangxiu Niu, Ming Yuan, Jingjing Chen, Liye Wang, Yueheng Qi, Kaiyue Bai, Yanli Fan & Panpan Gao. (2023) L-Cysteine-Modified Transfersomes for Enhanced Epidermal Delivery of Podophyllotoxin. Molecules 28:15, pages 5712.
Crossref
Crossref
Simone S. C. Oliveira, Claudyane A. Correia, Vanessa S. Santos, Elaine F. F. da Cunha, Alexandre A. de Castro, Teodorico C. Ramalho, Michael Devereux, Malachy McCann, Marta H. Branquinha & André L. S. Santos. (2023) Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin). Tropical Medicine and Infectious Disease 8:7, pages 348.
Crossref
Crossref
Charmante Registre, Rodrigo D. O. A. Soares, Karina T. S. Rubio, Orlando D. H. Santos & Simone P. Carneiro. (2023) A Systematic Review of Drug-Carrying Nanosystems Used in the Treatment of Leishmaniasis. ACS Infectious Diseases 9:3, pages 423-449.
Crossref
Crossref
Zahra Abpeikar, Mohsen Safaei, Ali Akbar Alizadeh, Arash Goodarzi & Gholamreza Hatam. (2023) The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis. International Journal of Pharmaceutics 633, pages 122615.
Crossref
Crossref
Eder Lilia Romero, Maria Julia Altube, Ana Paula Perez & Maria Jose Morilla. 2023. Biotechnology Applied to Inflammatory Diseases. Biotechnology Applied to Inflammatory Diseases
193
240
.
Hassan Raza, Shefaat Ullah Shah, Zakir Ali, Atif Ullah Khan, Irfa Basharat Rajput, Arshad Farid, Mohammed Al Mohaini, Abdulkhaliq J. Alsalman, Maitham A. Al Hawaj, Saima Mahmood, Abid Hussain & Kifayat Ullah Shah. (2022) In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis. Gels 8:11, pages 746.
Crossref
Crossref
Husna Khalid, Sibgha Batool, Fakhar ud Din, Salman Khan & Gul Majid Khan. (2022) Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis. Royal Society Open Science 9:10.
Crossref
Crossref
James H. Zothantluanga, Zonunmawii, Punamjyoti Das, Himangshu Sarma & Abd. Kakhar Umar. 2022. Phytoantioxidants and Nanotherapeutics. Phytoantioxidants and Nanotherapeutics
351
376
.
Érica Silva de Santana, Vanessa Brandão de Souza Belmiro, Luciana Betzler de Oliveira de Siqueira, Tatielle do Nascimento, Ralph Santos-Oliveira, Ana Paula dos Santos Matos & Eduardo Ricci-Junior. (2022) Nanotechnology as an alternative to improve the treatment of cutaneous leishmaniasis: A systematic review of the literature. Journal of Drug Delivery Science and Technology 75, pages 103622.
Crossref
Crossref
Fatima Zahid, Sibgha Batool, Fakhar ud-Din, Zakir Ali, Muhammad Nabi, Salman Khan, Omer Salman & Gul Majid Khan. (2022) Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity. AAPS PharmSciTech 23:6.
Crossref
Crossref
Kashif Iqbal, Sidra Khalid, Craig A McElroy, Muhammad Adnan, Gul Majid Khan & M Junaid Dar. (2022) Triple-combination therapy for cutaneous leishmaniasis using detergent-free, hyaluronate-coated elastic nanovesicles. Nanomedicine 17:20, pages 1429-1447.
Crossref
Crossref
Mariana B.C. Brioschi, Elizabeth M. Coser, Adriano C. Coelho, Fernanda R. Gadelha & Danilo C. Miguel. (2022) Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?. International Journal of Antimicrobial Agents 60:2, pages 106612.
Crossref
Crossref
Soumayya Aib, Kashif Iqbal, Nasir Khan, Sidra Khalid, Muhammad Adnan, Syed Muhammad Umair & M. Junaid Dar. (2022) pH-sensitive liposomes for colonic co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis. Journal of Drug Delivery Science and Technology 72, pages 103335.
Crossref
Crossref
João Paulo Assolini, Amanda Cristina Machado Carloto, Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto Pellissier, Paulo Emilio Feuser, Arthur Poester Cordeiro, Pedro Henrique Hermes de Araújo, Claudia Sayer, Milena Menegazzo Miranda Sapla & Wander Rogério Pavanelli. (2022) Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview. European Journal of Pharmacology 923, pages 174934.
Crossref
Crossref
Sidra Khalid, Saad Salman, Kashif Iqbal, Fiza ur Rehman, Iffat Ullah, Abhay R. Satoskar, Gul Majid Khan & M. Junaid Dar. (2022) Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine: Nanotechnology, Biology and Medicine 40, pages 102490.
Crossref
Crossref
Sandra Pacios-Michelena, José Daniel García-García, Rodolfo Ramos-González, Mónica Chávez-González, Elan Iñaky Laredo-Alcalá, Mayela Govea-Salas, Leticia A. Menchaca-Castro, Patricia Segura-Ceniseros, Alejandra Vargas-Segura, Roberto Arredondo-Valdes, José Luis Martínez-Hernández, Erika Nava-Reyna & Anna Ilyina. 2022. Bio-Based Nanoemulsions for Agri-Food Applications. Bio-Based Nanoemulsions for Agri-Food Applications
413
439
.
Muhammad Waseem Akram, Humzah Jamshaid, Fiza Ur Rehman, Muhammad Zaeem, Jehan zeb Khan & Ahmad Zeb. (2021) Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery. AAPS PharmSciTech 23:1.
Crossref
Crossref
Humzah Jamshaid, Fakhar ud Din & Gul Majid Khan. (2021) Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Pablo Oyarzún, Eduardo Gallardo-Toledo, Javier Morales & Francisco Arriagada. (2021) Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders. Nanomedicine 16:27, pages 2465-2489.
Crossref
Crossref
Stefan R. Stefanov & Velichka Y. Andonova. (2021) Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals 14:11, pages 1083.
Crossref
Crossref
C.A. Briones Nieva, Alicia Graciela Cid, Analía Irma Romero, María Fernanda García-Bustos, Mercedes Villegas & José María Bermúdez. (2021) An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis. Acta Tropica 221, pages 105988.
Crossref
Crossref
Amani Zoabi, Elka Touitou & Katherine Margulis. (2021) Recent Advances in Nanomaterials for Dermal and Transdermal Applications. Colloids and Interfaces 5:1, pages 18.
Crossref
Crossref
Sanaz Jafarpour Azami, Hanieh Mohammad Rahimi, Hamed Mirjalali & Mohammad Reza Zali. (2021) Unravelling Toxoplasma treatment: conventional drugs toward nanomedicine. World Journal of Microbiology and Biotechnology 37:3.
Crossref
Crossref
José Peña-Guerrero, Joan Puig-Rigall, Gustavo González-Gaitano & Paul Nguewa. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases
253
290
.
Muhammad Waqas Salim, Kanwal Shabbir, Fakhar ud-Din, Abid Mehmood Yousaf, Han-Gon Choi & Gul Majid Khan. (2020) Preparation, in-vitro and in-vivo evaluation of Rifampicin and Vancomycin Co-loaded transfersomal gel for the treatment of cutaneous leishmaniasis. Journal of Drug Delivery Science and Technology 60, pages 101996.
Crossref
Crossref
Muhammad Ijaz Khan Khattak, Naveed Ahmed, Muhammad Farooq Umer, Amina Riaz, Nasir Mehmood Ahmad & Gul Majid Khan. (2020) Chloroform-Injection (CI) and Spontaneous-Phase-Transition (SPT) Are Novel Methods, Simplifying the Fabrication of Liposomes with Versatile Solution to Cholesterol Content and Size Distribution. Pharmaceutics 12:11, pages 1065.
Crossref
Crossref
Raquel Fernández-García, Larry Statts, Jéssica A. de Jesus, Maria Auxiliadora Dea-Ayuela, Liliana Bautista, Rúben Simão, Francisco Bolás-Fernández, Maria Paloma Ballesteros, Marcia Dalastra Laurenti, Luiz F. D. PasseroAikaterini Lalatsa & Dolores R. Serrano. (2020) Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases. ACS Infectious Diseases 6:10, pages 2647-2660.
Crossref
Crossref